NCT02644577View on ClinicalTrials.gov

Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Bipolar Disorder
Interventions
DRUG

Metformin

OTHER

Starch

Trial Locations (1)

110001

Department of Psychiatry, the First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

China Medical University, China

OTHER

NCT02644577 - Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients | Biotech Hunter | Biotech Hunter